A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS

Adams, 2010, PHENIX: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925

Banerjee, 2019, Bats and Coronaviruses, Viruses, 11, 41, 10.3390/v11010041

Chen, 2017, A novel neutralizing monoclonal antibody targeting the N-terminal domain of the MERS-CoV spike protein, Emerg. Microbes Infect., 6, e37, 10.1038/emi.2017.50

Chiu, 2005, Human coronavirus NL63 infection and other coronavirus infections in children hospitalized with acute respiratory disease in Hong Kong, China, Clin. Infect. Dis., 40, 1721, 10.1086/430301

1994, The CCP4 suite: programs for protein crystallography, Acta Crystallogr. D Biol. Crystallogr., 50, 760, 10.1107/S0907444994003112

Corapi, 1992, Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus, J. Virol., 66, 6695, 10.1128/jvi.66.11.6695-6705.1992

Du, 2007, Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model, Vaccine, 25, 2832, 10.1016/j.vaccine.2006.10.031

Du, 2009, The spike protein of SARS-CoV--a target for vaccine and therapeutic development, Nat. Rev. Microbiol., 7, 226, 10.1038/nrmicro2090

Du, 2009, Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity, Virology, 393, 144, 10.1016/j.virol.2009.07.018

Du, 2013, A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccines, PLoS ONE, 8, e81587, 10.1371/journal.pone.0081587

Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158

Gorse, 2009, Human coronavirus and acute respiratory illness in older adults with chronic obstructive pulmonary disease, J. Infect. Dis., 199, 847, 10.1086/597122

Graham, 2020, Rapid COVID-19 vaccine development, Science, 368, 945, 10.1126/science.abb8923

He, 2004, Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine, Biochem. Biophys. Res. Commun., 324, 773, 10.1016/j.bbrc.2004.09.106

Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, 181, 271, 10.1016/j.cell.2020.02.052

Hohdatsu, 1998, Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus, J. Vet. Med. Sci., 60, 49, 10.1292/jvms.60.49

Hwang, 2006, Structural basis of neutralization by a human anti-severe acute respiratory syndrome spike protein antibody, 80R, J. Biol. Chem., 281, 34610, 10.1074/jbc.M603275200

Jaume, 2011, Anti-severe acute respiratory syndrome coronavirus spike antibodies trigger infection of human immune cells via a pH- and cysteine protease-independent FcγR pathway, J. Virol., 85, 10582, 10.1128/JVI.00671-11

Jean, 2013, Severity and outcome associated with human coronavirus OC43 infections among children, Pediatr. Infect. Dis. J., 32, 325, 10.1097/INF.0b013e3182812787

Jevšnik, 2012, Coronavirus infections in hospitalized pediatric patients with acute respiratory tract disease, BMC Infect. Dis., 12, 365, 10.1186/1471-2334-12-365

Jiang, 2012, Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndrome, Expert Rev. Vaccines, 11, 1405, 10.1586/erv.12.126

Jiang, 2020, Neutralizing antibodies against SARS-CoV-2 and other human coronaviruses, Trends Immunol., 41, 355, 10.1016/j.it.2020.03.007

Kam, 2007, Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro, Vaccine, 25, 729, 10.1016/j.vaccine.2006.08.011

Kim, 2018, Chaperna-mediated assembly of ferritin-based Middle East respiratory syndrome-coronavirus nanoparticles, Front. Immunol., 9, 1093, 10.3389/fimmu.2018.01093

Knipe, 2013

Lan, 2020, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor, Nature, 581, 215, 10.1038/s41586-020-2180-5

Li, 2003, Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus, Nature, 426, 450, 10.1038/nature02145

Li, 2005, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor, Science, 309, 1864, 10.1126/science.1116480

Li, 2005, Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies, J. Virol., 79, 10108, 10.1128/JVI.79.16.10108-10125.2005

Li, 2015, A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein, Cell Res., 25, 1237, 10.1038/cr.2015.113

Li, 2019, A novel bacterium-like particle vaccine displaying the MERS-CoV receptor-binding domain induces specific mucosal and systemic immune responses in mice, Viruses, 11, 799, 10.3390/v11090799

Lu, 2013, Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26, Nature, 500, 227, 10.1038/nature12328

Lu, 2015, Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond, Trends Microbiol., 23, 468, 10.1016/j.tim.2015.06.003

Ma, 2014, Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design, Vaccine, 32, 6170, 10.1016/j.vaccine.2014.08.086

Modjarrad, 2016, A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation, Nat. Med., 22, 701, 10.1038/nm.4131

Nie, 2020, Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2, Emerg. Microbes Infect., 9, 680, 10.1080/22221751.2020.1743767

Nyon, 2018, Engineering a stable CHO cell line for the expression of a MERS-coronavirus vaccine antigen, Vaccine, 36, 1853, 10.1016/j.vaccine.2018.02.065

Otwinowski, 1997, Processing of X-ray diffraction data collected in oscillation mode, Methods Enzymol., 276, 307, 10.1016/S0076-6879(97)76066-X

Pallesen, 2017, Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen, Proc. Natl. Acad. Sci. USA, 114, E7348, 10.1073/pnas.1707304114

Raj, 2013, Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC, Nature, 495, 251, 10.1038/nature12005

Read, 2001, Pushing the boundaries of molecular replacement with maximum likelihood, Acta Crystallogr. D Biol. Crystallogr., 57, 1373, 10.1107/S0907444901012471

Reed, 1938, A simple method of estimating fifty percent endpoints, Am. J. Epidemiol., 27, 493, 10.1093/oxfordjournals.aje.a118408

Robert, 2014, Deciphering key features in protein structures with the new ENDscript server, Nucleic Acids Res., 42, W320-4, 10.1093/nar/gku316

Shang, 2020, Structural basis of receptor recognition by SARS-CoV-2, Nature, 581, 221, 10.1038/s41586-020-2179-y

Shi, 2020, A human neutralizing antibody targets the receptor binding site of SARS-CoV-2, Nature, 10.1038/s41586-020-2381-y

Syed, 2018, Recombinant zoster vaccine (Shingrix®): A review in herpes zoster, Drugs Aging, 35, 1031, 10.1007/s40266-018-0603-x

Tai, 2016, A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection, Virology, 499, 375, 10.1016/j.virol.2016.10.005

Tang, 2015, Optimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus, Hum. Vaccin. Immunother., 11, 1244, 10.1080/21645515.2015.1021527

Valenzuela, 1982, Synthesis and assembly of hepatitis B virus surface antigen particles in yeast, Nature, 298, 347, 10.1038/298347a0

Vennema, 1990, Early death after feline infectious peritonitis virus challenge due to recombinant vaccinia virus immunization, J. Virol., 64, 1407, 10.1128/jvi.64.3.1407-1409.1990

Walls, 2020, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein, Cell, 181, 281, 10.1016/j.cell.2020.02.058

Wan, 2020, Molecular mechanism for antibody-dependent enhancement of coronavirus entry, J. Virol., 94, e02015, 10.1128/JVI.02015-19

Wang, 2013, Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4, Cell Res., 23, 986, 10.1038/cr.2013.92

Wang, 2014, Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins, Biochem. Biophys. Res. Commun., 451, 208, 10.1016/j.bbrc.2014.07.090

Wang, 2017, Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice, Antiviral Res., 140, 55, 10.1016/j.antiviral.2016.12.019

Wang, 2019, Structural definition of a neutralization-sensitive epitope on the MERS-CoV S1-NTD, Cell Rep., 28, 3395, 10.1016/j.celrep.2019.08.052

Wang, 2020, A novel coronavirus outbreak of global health concern, Lancet, 395, 470, 10.1016/S0140-6736(20)30185-9

Wang, 2020, Subunit vaccines against emerging pathogenic human coronaviruses, Front. Microbiol., 11, 298, 10.3389/fmicb.2020.00298

Wang, 2020, Structural and functional basis of SARS-CoV-2 entry by using human ACE2, Cell, 181, 894, 10.1016/j.cell.2020.03.045

Wei, 2020, Description of the first strain of 2019-nCoV, C-Tan-nCoV Wuhan strain-National Pathogen Resource Center, China, 2020, China CDC Weekly, 2, 61, 10.46234/ccdcw2020.023

Wevers, 2009, Recently discovered human coronaviruses, Clin. Lab. Med., 29, 715, 10.1016/j.cll.2009.07.007

Williams, 2018, MolProbity: More and better reference data for improved all-atom structure validation, Protein Sci., 27, 293, 10.1002/pro.3330

Wong, 2019, Global epidemiology of bat coronaviruses, Viruses, 11, 174, 10.3390/v11020174

Woo, 2009, Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus, J. Virol., 83, 908, 10.1128/JVI.01977-08

Wu, 2020, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2, Science, 368, 1274, 10.1126/science.abc2241

Xiao, 2004, Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain, Biochem. Biophys. Res. Commun., 322, 93, 10.1016/j.bbrc.2004.07.084

Yan, 2020, Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2, Science, 367, 1444, 10.1126/science.abb2762

Yuan, 2017, Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains, Nat. Commun., 8, 15092, 10.1038/ncomms15092

Zhang, 2015, Receptor-binding domain-based subunit vaccines against MERS-CoV, Virus Res., 202, 151, 10.1016/j.virusres.2014.11.013

Zhang, 2018, Structural definition of a unique neutralization epitope on the receptor-binding domain of MERS-CoV spike glycoprotein, Cell Rep., 24, 441, 10.1016/j.celrep.2018.06.041

Zhao, 2014, Rapid generation of a mouse model for Middle East respiratory syndrome, Proc. Natl. Acad. Sci. USA, 111, 4970, 10.1073/pnas.1323279111

Zhou, 2019, Structural definition of a neutralization epitope on the N-terminal domain of MERS-CoV spike glycoprotein, Nat. Commun., 10, 3068, 10.1038/s41467-019-10897-4

Zhou, 2019, Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain, Viruses, 11, E60, 10.3390/v11010060

Zhu, 2020, A novel coronavirus from patients with pneumonia in China, 2019, N. Engl. J. Med., 382, 727, 10.1056/NEJMoa2001017